Quidel Corporation Signs Definitive Agreement to Acquire Ortho Clinical Diagnostics

Quidel Corporation Signs Definitive Agreement to Acquire Ortho Clinical Diagnostics

On December 23, Quidel Corporation and Ortho Clinical Diagnostics Holdings plc announced that they have entered into a definitive agreement in which Quidel will acquire Ortho, one of the world’s largest in vitro diagnostics companies. The transaction, which is subject to approval by both companies’ shareholders as well as customary closing conditions and regulatory approvals, is expected to close in the first half of 2022. Quidel will acquire Ortho for $24.68 per share of common stock, for a total consideration of approximately $6.0 billion, including $1.75 billion of cash, funded through cash on the balance sheet and incremental borrowings. The combined company will also acquire Ortho’s... Read More »
DispatchHealth Buys Dynamic Mobile Imaging

DispatchHealth Buys Dynamic Mobile Imaging

On December 14, DispatchHealth announced that it has acquired Dynamic Mobile Imaging (DMI), a 24-hour mobile x-ray and ultrasound company servicing all of Virginia, Maryland and the Washington D.C. area. The financial terms of the transaction were not disclosed. DispatchHealth provides on-demand acute care and an advanced level of medical care for people of all ages in the comfort of their own homes. The company works closely with payers, providers, health systems, EMS, employer groups and others to deliver care in the home to reduce unnecessary emergency room visits, hospital stays and readmissions. Originally launched as an in-home care urgent care startup, DispatchHealth sees mobile... Read More »
Akumin Buys Alliance Healthcare Services

Akumin Buys Alliance Healthcare Services

The diagnostic imaging provider Akumin Inc. (NASDAQ: AKU) has announced a definitive agreement to acquire Alliance Healthcare Services for approximately $820 million.  Alliance HealthCare Services provides outsourced advanced radiology and radiation therapy services across 45 states in the U.S. Alliance partners with more than 1,000 hospitals, health systems and physician practices. It was owned by Tahoe Investment Group.  Upon closing of the transaction, the combined company will offer the most comprehensive radiology and oncology solutions to patients in the U.S., operating in 46 states, with more than 1,000 hospital and health system customers, 154 independent outpatient radiology... Read More »
Danaher Corporation Buys Aldevron

Danaher Corporation Buys Aldevron

The medical device giant Danaher Corporation (NYSE: DHR) is back with a new acquisition valued at nearly $10 billion. The company is buying Aldevron for $9.6 billion from private equity firm EQT Partners. Founded in 1998, Aldevron manufactures high-quality plasmid DNA, mRNA, and proteins, serving biotechnology and pharmaceutical customers across research, clinical and commercial applications. The business employs 600 people. No other financials for Aldevron were disclosed. The deal was financed by using cash on hand and/or proceeds from the issuance of commercial paper.  Aldevron will operate as a standalone operating company and brand within Danaher’s Life Sciences segment. The... Read More »
Unchained Labs Sold to The Carlyle Group

Unchained Labs Sold to The Carlyle Group

Private equity is branching out. Firms are usually swarming the physician group and behavioral health markets, building regional platforms, but we’re now seeing plenty of activity in new sectors, such as healthcare technology and research organizations. With fields such as diagnostics and gene therapy on the rise, it only makes sense for private equity to want a stake in the game. Last week, D.C.-based The Carlyle Group LP (NASDAQ: CG) announced it was buying Unchained Labs from Novo Holdings A/S, Canaan Partners, and TPG Biotech. The deal is valued at $435 million, or 5.80x Unchained Labs’ estimated 2021 revenue.  Unchained Labs is a life science tools company focused on solving problems... Read More »
SomaLogic Goes Public With SPAC

SomaLogic Goes Public With SPAC

They just don’t stop coming. Another private healthcare company has agreed to go public via SPAC in a $1.23 billion deal. SomaLogic is merging with CM Life Sciences II (NASDAQ: CMIIU), a special purpose acquisition company affiliated with Casdin Capital, LLC and Corvex Management LP. SomaLogic is a commercial-stage proteomics company with over 300 established industry partnerships and customers. The company’s pioneering technology platform, SomaScan Assay, measures 7,000 human proteins in a single sample, enabling the possibility of faster, more precise drug discovery for researchers. Artificial intelligence and machine learning-powered bioinformatics algorithms operating in tandem... Read More »